These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial. Andus T; Gross V; Caesar I; Schulz HJ; Lochs H; Strohm WD; Gierend M; Weber A; Ewe K; Schölmerich J; Dig Dis Sci; 2003 Feb; 48(2):373-8. PubMed ID: 12643618 [TBL] [Abstract][Full Text] [Related]
15. Adalimumab in steroid-dependent Crohn's disease patients: prognostic factors for clinical benefit. Orlando A; Renna S; Mocciaro F; Cappello M; Di Mitri R; Randazzo C; Cottone M Inflamm Bowel Dis; 2012 May; 18(5):826-31. PubMed ID: 21837774 [TBL] [Abstract][Full Text] [Related]
16. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862 [TBL] [Abstract][Full Text] [Related]
17. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Yacyshyn BR; Chey WY; Goff J; Salzberg B; Baerg R; Buchman AL; Tami J; Yu R; Gibiansky E; Shanahan WR; Gut; 2002 Jul; 51(1):30-6. PubMed ID: 12077088 [TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis for the treatment of Crohn's disease. Fowler S; Jones J; Hull PR; Ghosh S Transfus Apher Sci; 2015 Apr; 52(2):183-6. PubMed ID: 25747960 [TBL] [Abstract][Full Text] [Related]
19. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group. Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J Hepatogastroenterology; 1997; 44(14):445-51. PubMed ID: 9164517 [TBL] [Abstract][Full Text] [Related]
20. CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trial. Feagan BG; Sandborn WJ; Lichtenstein G; Radford-Smith G; Patel J; Innes A Aliment Pharmacol Ther; 2006 Mar; 23(5):617-28. PubMed ID: 16480401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]